Effects of Iron Chelating Therapy And/or HBV- Vaccination On β-Thalassemia Major Patients

Renal Functions in Pediatric Patients with β-Thalassemia Major: Relation to Iron Chelation Therapy

Highlights on Deferasirox Use and its Renal Toxicity in Children with Beta Thalassemia Major

Erythroferrone Level in β-thalassemia Patients

Evaluation of Iron overload in pediatric patients with beta thalassemia major

Assessment of Thalassemic Children Knowledge about Thalassemia and Iron Chelation Therapy

Clinical Evaluation of Αlpha-Lipoic Acid For Controlling Iron Overload-Induced Hepatotoxicity and Oxidative Stress In Beta Thalassemia Major Patients

Study of Erythroferone Hormone in Children with Beta Thalassemia Major

Effect of nursing care protocol on clinical outcomes of Thalassemic children who receiving iron chelation therapy

Serum Hepcidin and Growth Differentiation Factor 15 In Patients with β-thalassemia and Its Relation to Blood Transfusion